UnitedHealth Stock (UNH) Falls 10.2% on CMS Audit Proposal (Nov 18)

M Alfathan RahmanM Alfathan RahmanHendrie Saputra
Reviewed by Hendrie Saputra
AI-powered contentSome parts of this article are powered by AI.

Share this article

UnitedHealth Stock (UNH) Falls 10.2% on CMS Audit Proposal (Nov 18)

Summary

  • UnitedHealth (UNH) fell 10.21% to $349.91 on November 18, 2026, on volume of 17.4 million shares against a 5.9 million share average.
  • Financial media tied the sell-off to a CMS proposal to apply extrapolation to Medicare Advantage audits for payment year 2018 forward.
  • CMS estimates recoveries of about $9 billion per audit year across the industry, and the proposal is open for comment until January 19, 2027.

Gotrade News - In the latest UnitedHealth stock news, UnitedHealth (UNH) fell $39.77, or 10.21%, to close at $349.91 on Wednesday, November 18, 2026. UnitedHealth stock declined for a second session as financial media tied the selling to a federal proposal to expand Medicare Advantage audits.

UNH Trading Data

DataValue
Closing price$349.91
Change-$39.77 (-10.21%)
Previous close$389.68
Open$387.14
Day range$342.46 to $387.53
Volume17.4 million shares
30-day average volume5.9 million shares
52-week range$255.97 to $461.62
Market cap$313.5 billion

Regular-session close on Wednesday, November 18, 2026, 4:00 p.m. New York time. Stock prices: Yahoo Finance, cross-checked against the closing price on Nasdaq.com. Volume and 30-day average volume: Nasdaq.com. 52-week range: Yahoo Finance daily highs and lows since November 19, 2025. Indices: Yahoo Finance daily closes for the same date. 10-year Treasury yield: U.S. Treasury daily par yield curve for the same date.

Follow UNH's latest price on our UnitedHealth (UNH) stock price today page.

Read also: Microsoft Stock (MSFT) Rises 0.4% to $508.29 (Nov 18)

How UNH Traded in the Session

The stock opened at $387.14 and sold off through the day to a low of $342.46. It finished $7.46 above that low and far below the session high of $387.53. Trading was heavy, with 17.4 million shares changing hands, 196.32% above the 5.9 million share average.

The drop ran against the broader market. The Nasdaq Composite rose 0.42% to 24,429.88, leaving UNH 10.63 percentage points behind the index, while the S&P 500 slipped 0.23% to 7,323.63 and the Dow Jones Industrial Average lost 1.32% to 50,089.71. According to The Motley Fool, heavy selling across managed health care stocks weighed on the Dow. The US 10-year Treasury yield eased 3.0 basis points to 5.07%.

Other large health care names closed lower by smaller margins: Eli Lilly (LLY) fell 2.32% and Novo Nordisk (NVO) dropped 3.12%. UNH ended the session 24.20% below its 52-week high of $461.62 and 36.70% above its 52-week low of $255.97.

Read also: Micron Stock (MU) Falls 1.0% After Nvidia Earnings (Nov 18)

Why UnitedHealth Stock Fell

The selling traces to a proposed rule from the Centers for Medicare & Medicaid Services (CMS), announced on November 16 by the Department of Health and Human Services, as reported by Medical Daily. According to the CMS proposed rule (CMS-6098-P), the agency plans to apply extrapolation to Medicare Advantage risk adjustment data validation (RADV) audits for payment year 2018 forward and to require insurers to remit improper payments found in those audits. CMS estimates extrapolated recoveries of approximately $9 billion per audit year, beginning with the 2018 audits.

On Wednesday, health care stocks came under considerable pressure, with Humana falling nearly 13% alongside UnitedHealth, according to The Motley Fool. The outlet tied the sell-off to the federal proposal to expand Medicare Advantage audits and recover improper payments dating back to 2018, which it said could expose insurers to substantial financial liabilities. The move extended the 5.4% decline in UnitedHealth shares on November 17.

The broader CRUSH proposal targets fraud, waste and abuse in Medicare, Medicaid, CHIP and the Marketplace, and HHS projects it would save nearly $90 billion in federal spending over 10 years, per Medical Daily.

UNH Stock Analysis: Supporting Factors and Risks

Supporting Factors

  • The measure is a proposed rule, not a final one, and the public can comment until January 19, 2027, per Medical Daily.
  • CMS says it is reissuing the extrapolation provisions because a US District Court for the Northern District of Texas vacated similar provisions of a 2023 CMS final rule for procedural reasons, so the approach has been set aside in court once before.
  • The roughly $9 billion per audit year is CMS's estimate for the Medicare Advantage industry as a whole, not a figure specific to UnitedHealth.

Risks

  • The proposal would extrapolate audit findings from payment year 2018 forward and require insurers to remit improper payments, which could reach several past payment years if it is finalized as proposed.
  • CMS says it decided not to apply a fee-for-service (FFS) adjuster when calculating RADV overpayments, according to the proposed rule.
  • The selling reached beyond UnitedHealth, with Humana down nearly 13% in the same session, per The Motley Fool.

This article is for education and information only and is not investment advice. Investment decisions are yours to make after your own research.

Sources

Add as a preferred source on Google

Disclaimer

Gotrade is the trading name of Gotrade Securities Inc., which is registered with and supervised by the Labuan Financial Services Authority (LFSA). This content is for educational purposes only and does not constitute financial advice. Always do your own research (DYOR) before investing.


M Alfathan Rahman
Written by
M Alfathan Rahman
M. Alfathan Rahman is a content writer with over 3 years of experience developing digital content strategies across various industries, including fintech. He has experience producing content for tax-related websites and financial education platforms. His focus areas include data research, and crafting financial articles that are informative, accurate, and accessible to investors of all experience levels.
Read more
Hendrie Saputra
Reviewed by
Hendrie Saputra
Expert Reviewer
Hendrie Saputra holds a Master of Business Administration (MBA) with a concentration in Business Risk & Finance, along with professional experience in finance, marketing, and project management. He is experienced in analyzing market data and developing research-driven business strategies.
Read more

Related Articles

Welcome Reward up to $1,888

Create an account and trade US stocks on Gotrade

Download app

*Terms & conditions apply